<DOC>
	<DOCNO>NCT01381302</DOCNO>
	<brief_summary>The study population include 100 parkinsonian patient early stage disease , total duration exeeding 5 year . The patient undergo neurologic examination evaluation disease severity use unified PD rating scale . Subsequently brain SPECT perform use Tc-99m-Trodat1 .</brief_summary>
	<brief_title>Trodat 1 SPECT Dopamine Polymorphism</brief_title>
	<detailed_description>The study sample include 100 Israeli Jewish patient early idiopathic PD treat anti-parkinson drug . The clinical diagnosis base criterion United Kingdom Parkinson Disease Society Brain Bank.5 All patient undergo Tc-99m-Trodat1 SPECT . The severity motor symptom assess Unified PD Rating Scale ( UPDRS ) . Genomic DNA extract peripheral blood leukocyte genetic analysis .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<criteria>Inclusion criterion 1. early Israeli PD patient 2 . Of jewish origin , male females 3 . Undergoing DATscan examination Wolfson medical center early stage disease , accompany UPDRS evaluation stage , perform trained neurologist 4 . Patients use type antiparkinsonian drug type , time DATscan performance UPDRS evaluation 5 . DNA sample obtain 6 . Patients able sign inform consent form participate study . Patients exclude feature secondary parkinsonism treat medication block dopamine receptor .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Severity disease</keyword>
</DOC>